AI Maverick Intel Reports Strong Progress of HEAL Access Platform Ahead of Acquisition

AI Maverick Intel Inc. (OTC: AIMV) disclosed on Tuesday an update on the commercial progress of HEAL Access Canada Inc., the company it has a letter of intent to acquire. The update highlights that HEAL Access now has more than 10 live implementations, 13 signed enterprise agreements, and its platform is supporting approximately 79 clinicians and over 118,000 patients across multiple healthcare segments in North America and Europe.

The announcement underscores the momentum of HEAL Access's digital health platform, which is designed to improve patient access and care coordination. The company did not disclose financial terms of the acquisitions or the specific revenue generated from these implementations, but the metrics indicate a growing adoption of its technology. The full press release is available at https://ibn.fm/Wg0Jx.

AI Maverick Intel, based in the United States, focuses on identifying and developing opportunities at the intersection of artificial intelligence, data platforms, and emerging technology-enabled industries. The company evaluates strategic acquisitions, partnerships, and scalable platforms designed to drive long-term shareholder value. The proposed acquisition of HEAL Access aligns with this strategy, as HEAL Access's platform leverages data and AI to enhance healthcare delivery.

The update comes as part of AI Maverick's ongoing efforts to keep investors informed about the progress of its acquisition target. The company noted that the information is available in its newsroom at http://ibn.fm/AIMV.

This development is significant for stakeholders as it provides evidence that HEAL Access is gaining traction in the competitive healthcare technology market. The platform's ability to secure live implementations and enterprise agreements in both North America and Europe suggests a scalable solution that addresses real-world healthcare challenges. For AI Maverick, the successful integration of HEAL Access could accelerate its entry into the healthcare AI space and potentially enhance its revenue streams.

Investors should note that the acquisition is subject to customary closing conditions and regulatory approvals. The company has not provided a timeline for the completion of the transaction, but the update signals that the due diligence process is progressing alongside the operational achievements of HEAL Access.

As AI Maverick Intel continues to execute its growth strategy, the performance of HEAL Access will be a key indicator of the company's ability to deliver value through strategic acquisitions. The healthcare IT market is expanding rapidly, driven by digital transformation and the need for efficient patient management systems. HEAL Access's platform appears well-positioned to capitalize on these trends.